Related Experiment Video
Updated: May 22, 2026
04:59
Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
Published on: September 27, 2019
Gabapentin for pruritus in palliative care.
1Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, USA. sheeba14a@yahoo.co.in
Summary
Gabapentin effectively treats difficult itch (pruritus) in palliative care by blocking pain signals. This neuropathic pain medication offers a safe and effective option when standard treatments fail.
Area of Science:
- Palliative Care Medicine
- Neurology
- Dermatology
Background:
- Itch (pruritus) is a significant and challenging symptom in palliative care.
- Conventional antihistamines often lack efficacy for severe itch.
- The complex pathogenesis of itch involves both cutaneous and central mechanisms.
Purpose of the Study:
- To evaluate gabapentin as an antipruritic therapeutic option in palliative care.
- To explore the role of neuronal pathways in itch management.
- To assess the safety and efficacy of gabapentin for various types of pruritus.
Main Methods:
- Review of neuronal mechanisms in pruritus pathophysiology.
- Analysis of the interaction between pruritus and pain neuronal pathways.
- Clinical observation of gabapentin's effects on different pruritus etiologies.
Main Results:
- Gabapentin impedes nociceptive sensation transmission, thereby suppressing pruritus.
- Effective use of gabapentin observed in uremic, cancer-related, opioid-induced, brachioradial, and burn pruritus.
- Gabapentin demonstrates safety and efficacy as an antipruritic agent.
Conclusions:
- Gabapentin is a promising therapeutic option for refractory pruritus in palliative care.
- Neuropathic analgesics targeting neuronal pathways offer new avenues for itch treatment.
- Further research is needed to confirm the consistent effectiveness of gabapentin for diverse pruritus conditions.
Related Concept Videos
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...